217 related articles for article (PubMed ID: 27230801)
1. Preliminary observations regarding the expression of collagen triple helix repeat-containing 1 is an independent prognostic factor for Wilms' tumor.
Qi C; Hu Y; Yang F; An H; Zhang J; Jin H; Guo F
J Pediatr Surg; 2016 Sep; 51(9):1501-6. PubMed ID: 27230801
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological parameters and prognostic relevance of miR-21 and PTEN expression in Wilms' tumor.
Cui M; Liu W; Zhang L; Guo F; Liu Y; Chen F; Liu T; Ma R; Wu R
J Pediatr Surg; 2017 Aug; 52(8):1348-1354. PubMed ID: 28040201
[TBL] [Abstract][Full Text] [Related]
3. Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor.
Wang X; Du G; Wu Y; Zhang Y; Guo F; Liu W; Wu R
Int J Oncol; 2020 Feb; 56(2):568-580. PubMed ID: 31894270
[TBL] [Abstract][Full Text] [Related]
4. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
Lee CE; Vincent-Chong VK; Ramanathan A; Kallarakkal TG; Karen-Ng LP; Ghani WM; Rahman ZA; Ismail SM; Abraham MT; Tay KK; Mustafa WM; Cheong SC; Zain RB
Int J Med Sci; 2015; 12(12):937-45. PubMed ID: 26664254
[TBL] [Abstract][Full Text] [Related]
5. Collagen Triple Helix Repeat Containing 1 Expression in Osteosarcoma: A New Predictor of Prognosis.
Liu Y; Abulimiti N; Wang C
Ann Clin Lab Sci; 2018 May; 48(3):338-344. PubMed ID: 29970438
[TBL] [Abstract][Full Text] [Related]
6. Elevated CTHRC1 expression is an indicator for poor prognosis and lymph node metastasis in cervical squamous cell carcinoma.
Li N; Chen L; Liu C; Jiang Y; Rong J
Hum Pathol; 2019 Mar; 85():235-241. PubMed ID: 30381261
[TBL] [Abstract][Full Text] [Related]
7. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
Qi C; Ma H; Zhang HT; Gao JD; Xu Y
Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LINP1 induces tumorigenesis of Wilms' tumor by affecting Wnt/β-catenin signaling pathway.
Zhu KR; Sun QF; Zhang YQ
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5691-5698. PubMed ID: 31298321
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of nuclear unrest and p53 immunostaining in Wilms' tumor.
Salama A; Kamel A
J Egypt Natl Canc Inst; 2011 Mar; 23(1):31-9. PubMed ID: 22099934
[TBL] [Abstract][Full Text] [Related]
10. CTHRC1 is associated with peritoneal carcinomatosis in colorectal cancer: a new predictor for prognosis.
Tan F; Liu F; Liu H; Hu Y; Liu D; Li G
Med Oncol; 2013 Mar; 30(1):473. PubMed ID: 23359115
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of Wilms' tumor 1 and early growth response 1 proteins in nephroblastoma.
Ghanem MA; Van der Kwast TH; Den Hollander JC; Sudaryo MK; Oomen MH; Noordzij MA; Van den Heuvel MM; Nassef SM; Nijman RM; Van Steenbrugge GJ
Clin Cancer Res; 2000 Nov; 6(11):4265-71. PubMed ID: 11106242
[TBL] [Abstract][Full Text] [Related]
12. LncRNA XIST promotes migration of Wilms' tumor cells through modulation of microRNA-193a-5p.
Yao FZ; He R; Jiang YC; Hou Y; Qian D
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9889-9898. PubMed ID: 33090392
[TBL] [Abstract][Full Text] [Related]
13. Expression of TGF-β1 in Wilms' tumor was associated with invasiveness and disease progression.
Zhang L; Liu W; Qin Y; Wu R
J Pediatr Urol; 2014 Oct; 10(5):962-8. PubMed ID: 24559573
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of promoter hypomethylation and expression of p73 as a diagnostic and prognostic biomarker in Wilms' tumour.
Song D; Yue L; Wu G; Ma S; Yang H; Liu Q; Zhang D; Xia Z; Jia J; Wang J
J Clin Pathol; 2016 Jan; 69(1):12-8. PubMed ID: 26184366
[TBL] [Abstract][Full Text] [Related]
15.
Zhu S; Liu G; Fu W; Hu J; Fu K; Jia W
Onco Targets Ther; 2017; 10():955-963. PubMed ID: 28243131
[TBL] [Abstract][Full Text] [Related]
16. CTHRC1 Is Associated With Immune Escape and Poor Prognosis in Gastric Cancer.
Hu Y; Huang L; Zhao K; Li Y; Givens NT; Heslin AJ; Deng Z; Cao L; Fang Y
Anticancer Res; 2023 Jan; 43(1):115-126. PubMed ID: 36585164
[TBL] [Abstract][Full Text] [Related]
17. Assessment of promoter methylation and expression of SIX2 as a diagnostic and prognostic biomarker in Wilms' tumor.
Song D; Yue L; Wu G; Ma S; Guo L; Yang H; Liu Q; Zhang D; Xia Z; Wang L; Zhang J; Zhao W; Guo F; Wang J
Tumour Biol; 2015 Sep; 36(10):7591-8. PubMed ID: 25921281
[TBL] [Abstract][Full Text] [Related]
18. Expression of TCF3 in Wilms' tumor and its regulatory role in kidney tumor cell viability, migration and apoptosis
Zhou N; Yan B; Ma J; Jiang H; Li L; Tang H; Ji F; Yao Z
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278464
[TBL] [Abstract][Full Text] [Related]
19. Collagen triple helix repeat containing 1 (Cthrc1) is an independently prognostic biomarker of non-small cell lung cancers with cigarette smoke.
Liu X; Liu B; Cui Y; Wang F; Sun H; Lv F
Tumour Biol; 2014 Nov; 35(11):11677-83. PubMed ID: 25139095
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer.
Ke Z; He W; Lai Y; Guo X; Chen S; Li S; Wang Y; Wang L
Oncotarget; 2014 Oct; 5(19):9410-24. PubMed ID: 25238260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
